IMMX · Company research
Immix Biopharma, Inc. (IMMX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Understanding Momentum Shifts in (IMMX) - Stock Traders Daily | Understanding Momentum Shifts in (IMMX) Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 8, 2026 | neutral | 0 | 0.6 |
| San Francisco will host Immix Biopharma’s presentation Jan. 11–14. - Stock Titan | San Francisco will host Immix Biopharma’s presentation Jan. 11–14. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Immix Biopharma Prices $125 Million Equity Offering - The Globe and Mail | Immix Biopharma Prices $125 Million Equity Offering The Globe and Mail | View source ↗ | The Globe and Mail | Oct 1, 2026 | neutral | 0 | 0.6 |
| BofA Raises Odds Of Success For Immix Biopharma’s NXC-201 Therapy — Sees Over 190% Upside In IMMX Stock - Stocktwits | BofA Raises Odds Of Success For Immix Biopharma’s NXC-201 Therapy — Sees Over 190% Upside In IMMX Stock Stocktwits | View source ↗ | Stocktwits | Sep 29, 2026 | neutral | 0 | 0.6 |
| Immix posts new trial data for AL amyloidosis drug (IMMX) - Seeking Alpha | Immix posts new trial data for AL amyloidosis drug (IMMX) Seeking Alpha | View source ↗ | Seeking Alpha | Sep 29, 2026 | neutral | 0 | 0.6 |
| All 25 new patients had a complete response or tested negative for remaining disease - Stock Titan | All 25 new patients had a complete response or tested negative for remaining disease Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| Immix Biopharma (Nasdaq:IMMX) - Stock Analysis - Simply Wall Street | Immix Biopharma (Nasdaq:IMMX) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Sep 29, 2026 | neutral | 0 | 0.6 |
| Top BioTech SMidcap Stock: Mizuho Analyst Highlights IMMX - Investing.com | Top BioTech SMidcap Stock: Mizuho Analyst Highlights IMMX Investing.com | View source ↗ | Investing.com | Sep 16, 2026 | neutral | 0 | 0.6 |
| Liquidity Mapping Around (IMMX) Price Events - Stock Traders Daily | Liquidity Mapping Around (IMMX) Price Events Stock Traders Daily | View source ↗ | Stock Traders Daily | Aug 27, 2026 | neutral | 0 | 0.6 |
| Immix Biopharma Announces Participation in Morgan Stanley 24th Annual Global Healthcare Conference and Institutional Investor Meetings | IMMX Stock News - Quiver Quantitative | Immix Biopharma Announces Participation in Morgan Stanley 24th Annual Global Healthcare Conference and Institutional Investor Meetings | IMMX Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 4, 2026 | neutral | 0 | 0.6 |
| Immix Biopharma stock tumbles amid fugitive CMO report - Investing.com | Immix Biopharma stock tumbles amid fugitive CMO report Investing.com | View source ↗ | Investing.com | Jul 20, 2026 | neutral | 0 | 0.6 |
| IMMX ALERT: Immix Biopharma Investigated for Securities - GlobeNewswire | IMMX ALERT: Immix Biopharma Investigated for Securities GlobeNewswire | View source ↗ | GlobeNewswire | Jul 20, 2026 | neutral | 0 | 0.6 |
| IMMX Forecast — Price Target — Prediction for 2027 - TradingView | IMMX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Wall Street Analysts Think Immix Biopharma (IMMX) Could Surge 113.58%: Read This Before Placing a Bet - Zacks Investment Research | Wall Street Analysts Think Immix Biopharma (IMMX) Could Surge 113.58%: Read This Before Placing a Bet Zacks Investment Research | View source ↗ | Zacks Investment Research | Jun 18, 2026 | neutral | 0 | 0.6 |
| Is Immix Biopharma (IMMX) One of the Best Performing NASDAQ Stocks? - Yahoo Finance | Is Immix Biopharma (IMMX) One of the Best Performing NASDAQ Stocks? Yahoo Finance | View source ↗ | Yahoo Finance | May 5, 2026 | neutral | 0 | 0.6 |
| We Think Immix Biopharma (NASDAQ:IMMX) Can Afford To Drive Business Growth - Yahoo Finance | We Think Immix Biopharma (NASDAQ:IMMX) Can Afford To Drive Business Growth Yahoo Finance | View source ↗ | Yahoo Finance | May 5, 2026 | neutral | 0 | 0.6 |
| Analysts Expect Breakeven For Immix Biopharma, Inc. (NASDAQ:IMMX) Before Long - Simply Wall Street | Analysts Expect Breakeven For Immix Biopharma, Inc. (NASDAQ:IMMX) Before Long Simply Wall Street | View source ↗ | Simply Wall Street | Feb 16, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.